Indian drugmakers threaten to strike

Under government pricing pressure,  U.K. drugmakers  threatened to move away and Novartis invoked the old "loss of innovation" argument. Indian drugmakers are putting those protests to shame: Raise the prices on 33 bulk drugs immediately, they're telling the government, or we'll have to stop making them altogether. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.